Pages that link to "Q46958091"
Jump to navigation
Jump to search
The following pages link to Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker (Q46958091):
Displaying 14 items.
- Development of neuropeptide drugs that cross the blood-brain barrier (Q33569277) (← links)
- Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies (Q33996836) (← links)
- Advances in strategies to improve drug delivery to brain tumors (Q34000631) (← links)
- Endogenous carriers and ligands in non-immunogenic site-specific drug delivery (Q34019876) (← links)
- Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. (Q34489836) (← links)
- Drug and gene targeting to the brain with molecular Trojan horses (Q34742814) (← links)
- New systems for delivery of drugs to the brain in neurological disease (Q35172436) (← links)
- Targeted therapy for malignant glioma patients: lessons learned and the road ahead (Q37533648) (← links)
- Shuttle-mediated drug delivery to the brain (Q37896550) (← links)
- Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer (Q40647268) (← links)
- Localized lentivirus delivery via peptide interactions (Q40888779) (← links)
- Quantification of ligand surface concentration of bulk-modified biomimetic hydrogels (Q44551919) (← links)
- Synthesis of biotinylated aldehyde polymers for biomolecule conjugation (Q45167101) (← links)
- Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells (Q48895733) (← links)